FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Giovanni Luca Gravina

Research Profile

Disorders

Prostatic Neoplasms

Anatomy

Chemicals & Drugs

Physiology

Cell Proliferation

Phenomena

Blotting, Western

Living Beings

Co-author Network

Publications

TOP 3
Giovanni Luca Gravina; Andrea Mancini; Francesco Marampon; Guido Ranieri; Enrico Ricevuto; Luigi Di Clemente; Boris Di Pasquale; Claudio Festuccia
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
G Ciocca; S Di Sante; Sergio Di Tommaso; Giovanni Luca Gravina; Andrea Lenzi; E Limoncin; A Marcozzi; A Tullii; Eleonora Carosa; E A Jannini
Alexithymia and vaginismus: a preliminary correlation perspective.
Erika Limoncin; Vincenzo Mirone; Francesco Montorsi; Marco Tomassetti; Eleonora Carosa; Giacomo Ciocca; Stefania Di Sante; Vincenzo Gentile; Giovanni Luca Gravina; Andrea Lenzi; Emmanuele A Jannini
Premature ejaculation results in female sexual distress: standardization and validation of a new diagnostic tool for sexual distress.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Giovanni Luca Gravina (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Giovanni Luca Gravina; Andrea Mancini; Francesco Marampon; Guido Ranieri; Enrico Ricevuto; Luigi Di Clemente; Boris Di Pasquale; Claudio Festuccia
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
International journal of oncology 2013;42(6):2116-22.
2013: G Ciocca; S Di Sante; Sergio Di Tommaso; Giovanni Luca Gravina; Andrea Lenzi; E Limoncin; A Marcozzi; A Tullii; Eleonora Carosa; E A Jannini
Alexithymia and vaginismus: a preliminary correlation perspective.
International journal of impotence research 2013;25(3):113-6.
2013: Erika Limoncin; Vincenzo Mirone; Francesco Montorsi; Marco Tomassetti; Eleonora Carosa; Giacomo Ciocca; Stefania Di Sante; Vincenzo Gentile; Giovanni Luca Gravina; Andrea Lenzi; Emmanuele A Jannini
Premature ejaculation results in female sexual distress: standardization and validation of a new diagnostic tool for sexual distress.
The Journal of urology 2013;189(5):1830-5.
2013: Lorella Polidoro; Giuliana Properzi; L Scarsella; Bianca M Zani; Carmela Ciccarelli; E Di Cesare; Claudio Festuccia; Giovanni Luca Gravina; Francesco Marampon; C Ferri
Vitamin D protects human endothelial cells from H₂O₂ oxidant injury through the Mek/Erk-Sirt1 axis activation.
Journal of cardiovascular translational research 2013;6(2):221-31.
2013: Giovanni Luca Gravina; Andrea Mancini; Francesco Marampon; Paola Muzi; Guido Ranieri; Anna Maria D'Alessandro; Luigi Di Clemente; Boris Di Pasquale; Vincenza Dolo; Claudio Festuccia
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.
Oncology reports 2013;29(3):1189-95.
2012: Giovanni Luca Gravina; Carlo Masciocchi; Vincenzo Tombolini; Pierluigi Bonfili; Leda Di Nicola; Mario Di Staso; Pietro Franzese; Antonio Gennarelli; Ernesto Di Cesare
Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: what does the oncologist, radiotherapist and radiologist need to know?
European radiology 2012;22(12):2848-58.
2011: Giovanni Luca Gravina; Emmanuele A Jannini; Francesco Marampon; Marcella Motta; Richard G Pestell; Margherita Piccolella; Roberto Pomante; Vladimir M Popov; Vincenzo Tombolini; Luca Ventura; Bianca M Zani; Claudio Festuccia
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models.
Endocrinology 2011;152(12):4550-61.
2011: M Di Staso; P Franzese; Massimo Gallucci; Giovanni Luca Gravina; Francesco Marampon; Carlo Masciocchi; P Bonfili; A Conchiglia; L Di Nicola; L Ventura; Luigi Zugaro; Vincenzo Tombolini
A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases.
European radiology 2011;21(9):2004-10.
2011: Giovanni Luca Gravina; Emmanuele A Jannini; Francesco Marampon; Foteini Petini; David Sherris; Vincenzo Tombolini; Leda Biordi; Claudio Festuccia
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells.
Endocrine-related cancer 2011;18(4):385-400.
2011: Emmanuele A Jannini; Giovanni Luca Gravina; Abraham Mortengaler; Alvaro Morales; Luca Incrocci; Abraham Morgentaler; Wayne J G Hellstrom
Is testosterone a friend or a foe of the prostate?
The journal of sexual medicine 2011;8(4):946-55.
2011: Francesco Marampon; Giovanni Luca Gravina; Agnese Di Rocco; Pierluigi Bonfili; Mario Di Staso; Caterina Fardella; Lorella Polidoro; Carmela Ciccarelli; Claudio Festuccia; Vladimir M Popov; Richard G Pestell; Vincenzo Tombolini; Bianca M Zani
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals.
Molecular cancer therapeutics 2011;10(1):159-68.
2010: L Di Nicola; Giovanni Luca Gravina; Francesco Marampon; P Bonfili; S Buonopane; M Di Staso; Claudio Festuccia; P Franzese; M Tombolini; Vincenzo Tombolini
The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer.
Oncology reports 2010;24(5):1383-8.
2010: Claudio Festuccia; Donatella Dondi; Margherita Piccolella; Alessia Locatelli; Giovanni Luca Gravina; Vincenzo Tombolini; Marcella Motta
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.
The Prostate 2010;70(12):1340-9.
2010: Giovanni Luca Gravina; Francesco Marampon; Mario Di Staso; Pierluigi Bonfili; Alessandro Vitturini; Emmanuele A Jannini; Richard G Pestell; Vincenzo Tombolini; Claudio Festuccia
5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors.
The Prostate 2010;70(11):1166-78.
2010: Eleonora Carosa; Stefania Di Sante; Simona Rossi; Alessandra Castri; Fabio D'Adamo; Giovanni Luca Gravina; Piero Ronchi; Zdenek Kostrouch; Susanna Dolci; Andrea Lenzi; Emmanuele A Jannini
Ontogenetic profile of the expression of thyroid hormone receptors in rat and human corpora cavernosa of the penis.
The journal of sexual medicine 2010;7(4 Pt 1):1381-90.
2010: Vincenzo Tombolini; M Di Staso; P Bonfili; M Di Genesio Pagliuca; P Franzese; S Buonopane; M Valeriani; R Maurizi Enrici; Claudio Festuccia; Giovanni Luca Gravina
Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancer.
Prostate cancer and prostatic diseases 2010;13(1):34-8.
2010: Pierluigi Bonfili; Mario Di Staso; Giovanni Luca Gravina; Pietro Franzese; Sergio Buonopane; Francesca Soldà; Claudio Festuccia; Vincenzo Tombolini
Hypofractionated radical radiotherapy in elderly patients with medically inoperable stage I-II non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2010;67(1):81-5.
2009: Giovanni Luca Gravina; Leda Biordi; Francesco Martella; Vincenzo Flati; Enrico Ricevuto; Corrado Ficorella; Vincenzo Tombolini; Claudio Festuccia
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer.
International journal of oncology 2009;35(5):1133-9.
2009: Claudio Festuccia; Giovanni Luca Gravina; Leda Biordi; Sandra D'Ascenzo; Vincenza Dolo; Corrado Ficorella; Enrico Ricevuto; Vincenzo Tombolini
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro.
The Prostate 2009;69(14):1529-37.
2009: Emmanuele A Jannini; Andrea M Isidori; Giovanni Luca Gravina; Antonio Aversa; Giancarlo Balercia; Massimo Bocchio; Marco Boscaro; Cesare Carani; Giovanni Corona; Andrea Fabbri; Carlo Foresta; Gianni Forti; Sandro Francavilla; Antonio R M Granata; Mario Maggi; Riccardo Mansani; Pierfrancesco Palego; Giovanni Spera; Mario Vetri; Andrea Lenzi
The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
The journal of sexual medicine 2009;6(9):2547-60.
2009: Giovanni Luca Gravina; Claudio Festuccia; Danilo Millimaggi; Vincenzo Tombolini; Vincenza Dolo; Carlo Vicentini; Mauro Bologna
Bicalutamide demonstrates biologic effectiveness in prostate cancer cell lines and tumor primary cultures irrespective of Her2/neu expression levels.
Urology 2009;74(2):452-7.
2009: Claudio Festuccia; Giovanni Luca Gravina; Anna Maria D'Alessandro; Paola Muzi; Danilo Millimaggi; Vincenza Dolo; Enrico Ricevuto; Carlo Vicentini; Mauro Bologna
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
Endocrine-related cancer 2009;16(2):401-13.
2009: Claudio Festuccia; Giovanni Luca Gravina; Paola Muzi; Danilo Millimaggi; Vincenza Dolo; Carlo Vicentini; Corrado Ficorella; Enrico Ricevuto; Mauro Bologna
Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment.
The Prostate 2009;69(4):337-45.
2009: Eleonora Carosa; Simona Rossi; Nadia Giansante; Giovanni Luca Gravina; Alessandra Castri; Susanna Dolci; Flavia Botti; Annamaria Morelli; Luigi Di Luigi; Mario Pepe; Andrea Lenzi; Emmanuele Jannini
The ontogenetic expression pattern of type 5 phosphodiesterase correlates with androgen receptor expression in rat corpora cavernosa.
The journal of sexual medicine 2009;6(2):388-96.
2008: Claudio Festuccia; Giovanni Luca Gravina; Anna Maria D'Alessandro; Danilo Millimaggi; Cristiana Di Rocco; Vincenza Dolo; Enrico Ricevuto; Carlo Vicentini; Mauro Bologna
Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
International journal of oncology 2008;33(2):381-8.
2008: Claudio Festuccia; Giovanni Luca Gravina; Paola Muzi; Roberto Pomante; Adriano Angelucci; Carlo Vicentini; Mauro Bologna
Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386.
The Journal of urology 2008;180(1):367-72.
2008: Claudio Festuccia; Giovanni Luca Gravina; Paola Muzi; Danilo Millimaggi; Vincenza Dolo; Carlo Vicentini; Mauro Bologna
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors.
The Prostate 2008;68(9):965-74.
2008: Giovanni Luca Gravina; Claudio Festuccia; Danilo Millimaggi; Vincenza Dolo; Vincenzo Tombolini; Mariano de Vito; Carlo Vicentini; Mauro Bologna
Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
The Prostate 2008;68(7):793-801.
2008: Adriano Angelucci; Stefania Garofalo; Silvia Speca; Antonella Bovadilla; Giovanni Luca Gravina; Paola Muzi; Carlo Vicentini; Mauro Bologna
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells.
Endocrine-related cancer 2008;15(1):91-100.
2008: Giovanni Luca Gravina; Fulvia Brandetti; Paolo Martini; Eleonora Carosa; Savino M Di Stasi; Susanna Morano; Andrea Lenzi; Emmanuele Jannini
Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm.
The journal of sexual medicine 2008;5(3):610-8.
2008: Giuseppe Paradiso Galatioto; Giovanni Luca Gravina; Giovanni Angelozzi; Antonia Sacchetti; Pier Ferdinando Innominato; Gianna Pace; Guido Ranieri; Carlo Vicentini
May antioxidant therapy improve sperm parameters of men with persistent oligospermia after retrograde embolization for varicocele?
World journal of urology 2008;26(1):97-102.
2007: Claudio Festuccia; Giovanni Luca Gravina; Paola Muzi; Leda Biordi; Piero Ronchi; Oreste Martella; Carlo Vicentini; Mauro Bologna
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients.
Oncology reports 2007;18(5):1321-7.
2007: Giovanni Luca Gravina; Claudio Festuccia; Giuseppe Paradiso Galatioto; Paola Muzi; Adriano Angelucci; Piero Ronchi; Alessia Mariagrazia Costa; Mauro Bologna; Carlo Vicentini
Surgical and biologic outcomes after neoadjuvant bicalutamide treatment in prostate cancer.
Urology 2007;70(4):728-33.
2007: Claudio Festuccia; Giovanni Luca Gravina; Paola Muzi; Roberto Pomante; Luca Ventura; Robert L Vessella; Carlo Vicentini; Mauro Bologna
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer.
Endocrine-related cancer 2007;14(3):601-11.
2007: Giovanni Luca Gravina; Alessia Mariagrazia Costa; Giuseppe Paradiso Galatioto; Piero Ronchi; Andrea Tubaro; Carlo Vicentini
Urodynamic obstruction in women with stress urinary incontinence--do nonintubated uroflowmetry and symptoms aid diagnosis?
The Journal of urology 2007;178(3 Pt 1):959-63; discussion 963-4.
2007: Claudio Festuccia; Giovanni Luca Gravina; Paola Muzi; Roberto Pomante; Luca Ventura; Enrico Ricevuto; Carlo Vicentini; Mauro Bologna
In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
The Prostate 2007;67(12):1255-64.
2007: Claudio Festuccia; Giovanni Luca Gravina; Danilo Millimaggi; Paola Muzi; Silvia Speca; Enrico Ricevuto; Carlo Vicentini; Mauro Bologna
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells.
Oncology reports 2007;18(2):503-11.
2007: Duilio Divisi; Sergio Di Tommaso; Margherita Garramone; William Di Francescantonio; R M Crisci; A M Costa; Giovanni Luca Gravina; Roberto Crisci
Foreign bodies aspirated in children: role of bronchoscopy.
The Thoracic and cardiovascular surgeon 2007;55(4):249-52.
2007: Giovanni Luca Gravina; Alessia Mariagrazia Costa; Piero Ronchi; Giuseppe Paradiso Galatioto; Gualà Luana; Carlo Vicentini
Bladder outlet obstruction index and maximal flow rate during urodynamic study as powerful predictors for the detection of urodynamic obstruction in women.
Neurourology and urodynamics 2007;26(2):247-53.
2007: Claudio Festuccia; Paola Muzi; Giovanni Luca Gravina; Danilo Millimaggi; Silvia Speca; Vincenza Dolo; Enrico Ricevuto; Carlo Vicentini; Mauro Bologna
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
International journal of oncology 2007;30(1):193-200.
2006: Adriano Angelucci; Silvia Schenone; Giovanni Luca Gravina; Paola Muzi; Claudio Festuccia; Carlo Vicentini; Maurizio Botta; Mauro Bologna
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells.
European journal of cancer (Oxford, England : 1990) 2006;42(16):2838-45.
2006: Adriano Angelucci; Giovanni Luca Gravina; Nadia Rucci; Danilo Millimaggi; Claudio Festuccia; Paola Muzi; Anna Teti; Carlo Vicentini; Mauro Bologna
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.
Endocrine-related cancer 2006;13(1):197-210.
2005: Claudio Festuccia; Paola Muzi; Danilo Millimaggi; Leda Biordi; Giovanni Luca Gravina; Silvia Speca; Adriano Angelucci; Vincenza Dolo; Carlo Vicentini; Mauro Bologna
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Endocrine-related cancer 2005;12(4):983-98.
2005: Giovanni Luca Gravina; Alessia Mariagrazia Costa; Piero Ronchi; Giuseppe Paradiso Galatioto; Adriano Angelucci; Daniele Castellani; Federico Narcisi; Carlo Vicentini
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones.
Urology 2005;66(1):24-8.
2005: Claudio Festuccia; Giovanni Luca Gravina; Adriano Angelucci; Danilo Millimaggi; Paola Muzi; Carlo Vicentini; Mauro Bologna
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro.
International journal of cancer. Journal international du cancer 2005;115(4):630-40.
2005: Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; Leda Biordi; Danilo Millimaggi; Paola Muzi; Carlo Vicentini; Mauro Bologna
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Thrombosis and haemostasis 2005;93(5):964-75.
2005: Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; Paola Muzi; Roberto Miano; Carlo Vicentini; Mauro Bologna
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
International journal of oncology 2005;26(5):1353-62.
2005: Francesca Margheri; Silvia D'Alessio; S Serratí; Marco Pucci; Francesco Annunziato; Lorenzo Cosmi; Francesco Liotta; Roberta Angeli; Adriano Angelucci; Giovanni Luca Gravina; Nadia Rucci; Mauro Bologna; A Teti; Brett P Monia; Gabriella Fibbi; Mario Del Rosso
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases.
Gene therapy 2005;12(8):702-14.
2005: Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; Paola Muzi; Carlo Vicentini; Mauro Bologna
Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.
Journal of cancer research and clinical oncology 2005;131(4):243-54.
2004: Adriano Angelucci; Giovanni Luca Gravina; Nadia Rucci; Claudio Festuccia; Paola Muzi; Carlo Vicentini; Anna Teti; Mauro Bologna
Evaluation of metastatic potential in prostate carcinoma: an in vivo model.
International journal of oncology 2004;25(6):1713-20.
2004: Giovanni Luca Gravina; Claudio Festuccia; Adriano Angelucci; Angelo Poletti; Daila Capuano; Carlo Vicentini; Marcella Motta; Mauro Bologna
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells.
International journal of oncology 2004;25(1):97-104.
2004: Adriano Angelucci; Claudio Festuccia; Giovanni Luca Gravina; Paola Muzi; Loriana Bonghi; Carlo Vicentini; Mauro Bologna
Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells.
The Prostate 2004;59(2):157-66.
2004: Carlo Vicentini; Giovanni Luca Gravina; Adriano Angelucci; Esterina Pascale; Ettore D'Ambrosio; Paola Muzi; Gabriella Di Leonardo; Antonio Fileni; Andrea Tubaro; Claudio Festuccia; Mauro Bologna
Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.
Journal of cancer research and clinical oncology 2004;130(4):217-21.
2003: Carlo Vicentini; Claudio Festuccia; Giovanni Luca Gravina; Adriano Angelucci; Angelo Marronaro; Mauro Bologna
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.
Journal of cancer research and clinical oncology 2003;129(3):165-74.
2002: Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; Enrica Eleuterio; Carlo Vicentini; Mauro Bologna
Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement.
Experimental cell research 2002;280(1):1-11.
2002: Carlo Vicentini; Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; Paola Muzi; Enrica Eleuterio; Roberto Miano; Angelo Marronaro; Andrea Tubaro; Mauro Bologna
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures.
Anticancer research 2002;22(5):2917-22.
2000: Claudio Festuccia; Giovanni Luca Gravina; Adriano Angelucci; Danilo Millimaggi; Mauro Bologna
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell line.
Anticancer research 2000;20(6B):4367-71.
2000: Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; I Villanova; Anna Teti; A Albini; Mauro Bologna; A Abini
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
International journal of cancer. Journal international du cancer 2000;85(3):407-15.
2000: Adriano Angelucci; Sandra D'Ascenzo; Claudio Festuccia; Giovanni Luca Gravina; Mauro Bologna; Vincenza Dolo; Antonio Pavan
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.
Clinical & experimental metastasis 2000;18(2):163-70.
1999: Claudio Festuccia; Mauro Bologna; Giovanni Luca Gravina; F Guerra; Adriano Angelucci; I Villanova; Danilo Millimaggi; Anna Teti
Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components.
International journal of cancer. Journal international du cancer 1999;81(3):395-403.